If you are one of the 2.5 million people worldwide living with multiple sclerosis, you likely already know some of the challenges of staying active with the condition. Hearing the words “you have MS” ...

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) said Tuesday that phase 3 RELEASE MSS1 trial, which evaluated nabiximols oromucosal spray on clinical measures of spasticity in individuals with multiple ...

Medicinal cannabinoids are helpful for treatment of spasticity, pain, and bladder dysfunction for patients with multiple sclerosis (MS), although their efficacy is "limited," new research suggests.

Credit: Getty Images. The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple sclerosis. Topline results were announced from a phase 3 trial evaluating the ...